NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SyMap Medical

SyMap Medical

Private
SuzhouHealthcare & Life Scienceshttps://www.symapmedical.com/

Last Round

Series E

Dec 1, 2021

Total Funding Raised

$135.5M

Company Overview

SyMap Medical is a medical device company that develops and manufactures minimally invasive interventional devices for the treatment of cardiovascular and respiratory diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

renal denervationRDNradiofrequency ablationhypertension treatmentinterventional cardiologynerve mappingmedical devicebronchial ablationdrug-resistant hypertensioncatheter-based therapyblood pressure managementminimally invasive surgeryinterventional medicinemedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SyMap Medical Comps

Public and private peers based on sector, stage, and business model.

SyMap Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SyMap Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series EDec 1, 2021
Series DDec 22, 2020
Series CNov 1, 2018
Series BAug 22, 2015

SyMap Medical Investors

Notable investors and investment history

SyMap Medical investors
InvestorRounds
VMS Asset ManagementSeries E
HongShanSeries E, Series B
Puhua CapitalSeries D
SB China CapitalSeries B
Primavera Capital GroupSeries E

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 17, 2024

    Monthly visitors increased 511% MoM.

  • Aug 22, 2015

    $10M round led by HongShan

SyMap Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SyMap Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SyMap Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersSuzhou
Employee Range1
Year Founded2012
Last FundingDec 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.